Olopatadine hydrochloride and Rashes - a phase IV clinical study of FDA data

Summary:

We study 4,113 people who have side effects when taking Olopatadine hydrochloride. Rashes is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Maxipime and have Fever.

The phase IV clinical study analyzes which people take Olopatadine hydrochloride and have Rashes. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 29, 2023

4,113 people reported to have side effects when taking Olopatadine hydrochloride.
Among them, 196 people (4.77%) have Rashes.

What is Olopatadine hydrochloride?

Olopatadine hydrochloride has active ingredients of olopatadine hydrochloride. Currently, eHealthMe is studying from 4,134 Olopatadine hydrochloride users.

What is Rashes?

Rashes (redness) is found to be associated with 5,185 drugs and 6,079 conditions by eHealthMe. Currently, we are studying 662,188 people who have Rashes.

Number of Olopatadine hydrochloride and Rashes reports submitted per year:

Could Olopatadine hydrochloride cause Rashes?

* Approximation only. Some reports may have incomplete information.

Do you take Olopatadine hydrochloride and have Rashes?

Check whether Rashes is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Olopatadine hydrochloride side effects by duration, gender and age:

Olopatadine hydrochloride side effects (4,134 reports)

Rashes treatments and more:

Rashes (662,188 reports)

Common drugs associated with Rashes:

All the drugs that are associated with Rashes:

Rashes (5,185 drugs)

Common conditions associated with Rashes:

Rheumatoid arthritis: 43,808 reports
Acne: 29,888 reports
High blood pressure: 18,830 reports
Multiple myeloma: 18,803 reports
Multiple sclerosis: 18,022 reports

All the conditions that are associated with Rashes:

Rashes (6,079 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olopatadine hydrochloride (the active ingredients of Olopatadine hydrochloride) and Olopatadine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.